34 results on '"Gunes, Arzu"'
Search Results
2. The Antiplatelet Effect of Higher Loading and Maintenance Dose Regimens of Clopidogrel: The PRINC (Plavix Response in Coronary Intervention) Trial
Catalog
Books, media, physical & digital resources
3. Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting
4. Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients
5. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients
6. Impact of serotonin receptor 2A gene haplotypes on C-peptide levels in clozapine- and olanzapine-treated patients
7. Flavin-containing monooxygenase 3 polymorphisms in 13 ethnic populations from Europe, East Asia and sub-Saharan Africa: frequency and linkage analysis
8. Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population
9. Variation in CYP1A2 activity and its clinical implications:: influence of environmental factors and genetic polymorphisms
10. Inhibitory Effect of Valproic Acid on Cytochrome P450 2C9 Activity in Epilepsy Patients
11. Could endogenous substrates of drug-metabolizing enzymes influence constitutive physiology and drug target responsiveness?
12. Inhibitory Effect of 5-Fluorouracil on Cytochrome P450 2C9 Activity in Cancer Patients
13. Pharmacogenetics and Antipsychotic Treatment in Schizophrenia with Special Focus on Adverse Drug Reactions
14. Cytochrome P4502C9 (CYP2C9) polymorphism influences hypoglycaemic attacks induced by sulphonylurea treatment
15. Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine and clozapine
16. ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety
17. Further evidence for association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients
18. Impact of CYP1A2 and CYP2D6 polymorphisms on drug metabolism and on insulin and lipid elevations and insulin resistance in clozapine-treated patients
19. Could endogenous substrates of drug-metabolizing enzymes influence constitutive physiology and drug target responsiveness?
20. Pacific Rim Association for Clinical Pharmacogenetics - 13 Annual Conferece : Pharmacogenetics-based individualised therapy
21. Circadian variations in the activities of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in the liver of control and streptozotocin-induced diabetic rats.
22. Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats : effects of in vivo treatment with antioxidants.
23. Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics
24. Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine
25. ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active Moiety
26. The Pharmacogenomics and Pharmacodynamics of Clopidogrel Response: An Analysis From the PRINC (Plavix Response in Coronary Intervention) Trial
27. Impact of CYP1A2 and CYP2D6 Polymorphisms on Drug Metabolism and on Insulin and Lipid Elevations and Insulin Resistance in Clozapine-Treated Patients
28. Inhibitory effect of valproic acid on cytochrome P450 2C9 activity in epilepsy patients
29. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients
30. Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients.
31. Association Between HTR2Cand HTR2APolymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine
32. ABCB1Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active Moiety
33. The Antiplatelet Effect of Higher Loading and Maintenance Dose Regimens of Clopidogrel The PRINC (Plavix Response in Coronary Intervention) Trial
34. The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response An Analysis From the PRINC (Plavix Response in Coronary Intervention) Trial
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.